The Effectiveness of Bleach in the Prevention
of Hepatitis C Transmission - Final Report
References
- Zou, S., Vardy, L. and Giulivi, A. Prevention and Control of Viral Hepatitis and Emerging Bloodborne Pathogens in Canada. Can Commun Dis Rep, 2001. 27 Suppl 3: p. 13-15.
- Hepatitis C-prevent ion and control: a public health consensus. Ottawa, Canada, October 14-16, 1998. Can Commun Dis Rep, 1999. 25 Suppl 2: p. i-iii, 1-25.
- Hepatitis. 2002, Health Canada. Ottawa, ON.
- Hepatitis C & Injection Drug Use. 2001, Health Canada. Ottawa, ON.
- Hepatitis C and Why is it a Problem? 2001, Health Canada. Ottawa, ON.
- Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. Centers for Disease Control and Prevention. MMWR Recomm Rep, 1998. 47(RR-19): p. 1-39.
- Alter, M.J., et al., Hepatitis C. Infect Dis Clin North Am, 1998. 12(1): p. 13-26.
- Page-Shafer, K.A., et al., Hepatitis C virus infection in young, low-income women: the role of sexually transmitted infection as a potential co-factor for HCV infection. Am J Public Health, 2002. 92(4): p. 670-6.
- Bigham, M., Informed Decision-making about Mother-to-child Transmission of Hepatitis C Virus by Breastfeeding. 2000, BC Centre for Disease Control Society: Vancouver, BC.
- Granovsky, M.O., et al., Hepatitis C virus infection in the mothers and infants cohort study. Pediatrics, 1998. 102(2 Pt 1): p. 355-9.
- Hepatitis C: medical information update. Canadian Liver Foundation. National Hepatitis C Education Program. Can J Public Health, 2000. 91 Suppl 1: p. S4-9.
- Patrick, D.M., et al., Public health and hepatitis C. Can J Public Health, 2000. 91 Suppl 1: p.S18-21, S19-23.
- Hepatitis C. Centers for Disease Control and Prevention. Hepatitis Branch. 2000: Atlanta, GA.
- Weinstock, H.S., et al., Hepatitis C virus infection among patients attending a clinic for sexually transmitted diseases. JAMA, 1993. 269(3): p. 392-4.
- Leonard, L., et al., The Effectiveness of Harm Reduction Strategies in Modifying Hepatitis C Infection among Injection Drug Users in Canada. Can Commun Dis Rep, 2001. 27 Suppl 3: p 52-55
- Anderson, F.H., ed., N. Rock, ed., and S. Campbell, ed., The Hepatitis Knowledge Newsletter: Hep C: Transmission. n.d., HepNet: The Hepatitis Information Network.
- Rose, V.L., CDC issues new recommendations for the prevention and control of hepatitis C virus infection. Am Fam Physician, 1999. 59(5): p. 1321-3.
- Sattar, S.A., et al., Preventing the spread of hepatitis B and C viruses: where are germicides relevant? Am J Infect Control, 2001. 29(3): p. 187-97.
- Sherman, M., The HepUpdate series: Update 1 - Fall 1995: How Significant is hepatitis C infection in Canada? 1995, HepNet: The Hepatitis Information Network.
- Gully, P.R. and M.L. Tepper, Hepatitis C. CMAJ, 1997. 156(10): p. 1427-30.
- Alter, M.J., et al., The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med, 1999. 341(8): p. 556-62.
- Preventing the transmission of bloodborne pathogens in health care and public service settings. Can Commun Dis Rep, 1997. 23 Suppl 3: p. i-vii, 1-43, i-vii, 1-52.
- Strathdee, S.A., et al., Needle exchange is not enough: lessons from the Vancouver injecting drug use study. AIDS, 1997. 11(8): p. F59-65.
- Patrick, D.M., et al., Incidence of hepatitis C virus infection among injection drug users during an outbreak of HIV infection. CMAJ, 2001. 165(7): p. 889-95.
- Ford, P.M., et al., Seroprevalence of hepatitis C in a Canadian federal penitentiary for women. Can Commun Dis Rep, 1995. 21(14): p. 132-4.
- Pearson, M., P.S. Mistry, and P.M. Ford, Voluntary screening for hepatitis C in a Canadian federal penitentiary for men. Can Commun Dis Rep, 1995. 21(14): p. 134-6.
- Roy, E., et al., Risk factors for hepatitis C virus infection among street youths. CMAJ, 2001. 165(5): p. 557-60.
- Falck-Ytter, Y., et al., Surprisingly small effect of antiviral treatment in patients with hepatitis C. Ann Intern Med, 2002. 136(4): p. 288-92.
- Manns, M.P., et al., Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet, 2001. 358(9286): p. 958-65.
- Lauer, G.M. and B.D. Walker, Hepatitis C virus infection. N Engl J Med, 2001. 345(1): p. 41-52.
- Sievert, W., Management issues in chronic viral hepatitis: hepatitis C. J Gastroenterol Hepatol, 2002. 17(4): p. 415-22.
- Wiebe, J. and B. Reimer, Profile of Hepatitis C & Injection Drug Use in Canada. A Discussion Paper. Prepared for Hepatitis C Prevention, Support & Research Program. Population & Public Health Branch. Health Canada. 2000, Canadian Centre on Substance Abuse (CCSA): Ottawa, ON.
- Preventing HIV Transmission: The Role of Sterile Needles and Bleach, ed. J. Normand, D. Vlahov, and L.E. Moses. 1995, Washington: National Academy Press.
- Thorpe, L.E., et al., Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment. Am J Epidemiol, 2002. 155(7): p. 645-53.
- Wood, E., et al., Unsafe injection practices in a cohort of injection drug users in Vancouver: could safer injecting rooms help? CMAJ, 2001. 165(4): p. 405-10.
- Samuel, M.C., et al., Association between heroin use, needle sharing and tattoos received in prison with hepatitis B and C positivity among street-recruited injecting drug users in New Mexico, USA. Epidemiol Infect, 2001. 127(3): p. 475-84.
- Kwiatkowski, C.F., K. Fortuin Corsi, and R.E. Booth, The association between knowledge of hepatitis C virus status and risk behaviors in injection drug users. Addiction, 2002. 97(10): p. 1289-94.
- Jurgen, R. and D. Riley, Responding to AIDS and Drug Use in Prisons in Canada. 1997.
- Kleinman, S., et al., The incidence/window period model and its use to assess the risk of transfusion-transmitted human immunodeficiency virus and hepatitis C virus infection. Transfus Med Rev, 1997. 11(3): p. 155-72.
- Fletcher, J. and D. Ciancone, Why life's a bleach (The Sodium Hypochlorite Story). Environmental Science & Engineering, 1996.
- Newmeyer, J.A., Why bleach? Fighting AIDS contagion among intravenous drug users: the San Francisco experience. J Psychoactive Drugs, 1988. 20(2): p. 159-63.
- Romanelli, F., K.M. Smith, and C. Pomeroy, Reducing the transmission of HIV-1: needle bleaching as a means of disinfection. J Am Pharm Assoc (Wash), 2000. 40(6): p. 812-7.
- Ogborne, A.C., V. Carver, and J. Wiebe, Harm Reduction and Injection Drug Use: an international comparative study of contextual factors influencing the development and implementation of relevant policies and programs. 2001, Health Canada.
- Rutala, W.A., et al., Stability and bactericidal activity of chlorine solutions. Infect Control Hosp Epidemiol, 1998. 19(5): p. 323-7.
- Sehulster, L.M., et al., Immunological and biophysical alteration of hepatitis B virus antigens by sodium hypochlorite disinfection. Appl Environ Microbiol, 1981. 42(5): p. 762-7.
- Carlson, R.G., et al., A preliminary evaluation of a modified needle-cleaning intervention using bleach among injection drug users. AIDS Educ Prev, 1998. 10(6): p. 523-32.
- Hilfenhaus, J., et al., Analysis of human plasma products: polymerase chain reaction does not discriminate between live and inactivated viruses. Transfusion, 1997. 37(9): p. 935-40.
- Borovec, S., et al., Inactivation kinetics of model and relevant blood-borne viruses by treatment with sodium hydroxide and heat. Biologicals, 1998. 26(3): p. 237-44.
- Shapshak, P., et al., Preliminary laboratory studies of inactivation of HIV-1 in needles and syringes containing infected blood using undiluted household bleach. J Acquir Immune Defic Syndr, 1994. 7(7): p. 754-9.
- Update on the Use of Bleach to Prevent Transmission of HIV and Hepatitis among Injection Drug Users. 1999, Public Health Seattle & King County.
- Clarkson, R.M., A.J. Moule, and H.M. Podlich, The shelf-life of sodium hypochlorite irrigating solutions. Aust Dent J, 2001. 46(4): p. 269-76.
- Kapadia, F., et al., Does bleach disinfection of syringes protect against hepatitis C infection among young adult injection drug users? Epidemiology, 2002. 13(6): p. 738-41.
- Agolini, G., A. Russo, and M. Clementi, Effect of phenolic and chlorine disinfectants on hepatitis C virus binding and infectivity. Am J Infect Control, 1999. 27(3): p. 236-9.
- Charrel, R.N., et al., Evaluation of disinfectant efficacy against hepatitis C virus using a RT-PCR-based method. J Hosp Infect, 2001. 49(2): p. 129-34.
- Jamner, M.S., N.H. Corby, and R.J. Wolitski, Bleaching injection equipment: influencing factors among IDUs who share. Subst Use Misuse, 1996. 31(14): p. 1973-93.
- Watters, J.K., Historical perspective on the use of bleach in HIV/AIDS prevention. J Acquir Immune Defic Syndr, 1994. 7(7): p. 743-6.
- Use of bleach for disinfection of drug injection equipment. MMWR Morb Mortal Wkly Rep, 1993. 42(21): p. 418-9.
- Knowledge and Practices Among Injecting-Drug Users of Bleach Use for Equipment Disinfection - New York city, 1993 . MMWR Morb Mortal Wkly Rep, 1994. 43(24): p. 445-446.
- Haverkos, H.W. and T.S. Jones, HIV, drug-use paraphernalia, and bleach. J Acquir Immune Defic Syndr, 1994. 7(7): p. 741-2.
- Rietmeijer, C.A., et al., Increasing the use of bleach and condoms among injecting drug users in Denver: outcomes of a targeted, community-level HIV prevention program. AIDS, 1996. 10(3): p. 291-8.
- Hahn, J.A., et al., Hepatitis C virus infection and needle exchange use among young injection drug users in San Francisco. Hepatology, 2001. 34(1): p. 180-7.
- Hong, Z., S. Zou, and A. Giulivi, Hepatitis B and its Control in Southeast Asia and China. Can Commun Dis Rep, 2001. 27 Suppl 3: p. 31-33.
- Zhang, J., S. Zou, and A. Giulivi, Hepatitis B in Canada. Can Commun Dis Rep, 2001. 27 Suppl 3: p. 10-12.
- Rutala, W.A., APIC guideline for selection and use of disinfectants. Am J Infect Control, 1990. 18(2): p. 99-117.
- Bond, W.W., et al., Inactivation of hepatitis B virus by intermediate-to-high-level disinfectant chemicals. J Clin Microbiol, 1983. 18(3): p. 535-8.
- Payan, C., et al., Inactivation of hepatitis B virus in plasma by hospital in-use chemical disinfectants assessed by a modified HepG2 cell culture. J Hosp Infect, 2001. 47(4): p. 282-7.
- Thraenhart, O. and C. Jursch, Measures for Disinfection and Control of Viral Hepatitis, in Disinfection, Sterilization, and Preservation, S.S. Block, Editor. 2001, Lippincott Williams & Wilkins: Philadelphia. p. 585-615.
- Gayle, H.D., J.F. O'Neill, and S.W. Gust, HIV Prevention Bulletin: Medical Advice for Persons Who Inject Illicit Drugs. 1997, Centers for Disease Control and Prevention. Divisions of HIV/AIDS Prevention. Altanta, GA.
- HIV and AIDS in Canada: Surveillance Report to June 30, 2001. 2001, Health Canada: Ottawa, ON. p. 52.
- Abdala, N., et al., Can HIV-1-contaminated syringes be disinfected? Implications for transmission among injection drug users. J Acquir Immune Defic Syndr, 2001. 28(5): p. 487-94.
- Heimer, R., Syringe exchange programs: lowering the transmission of syringe-borne diseases and beyond. Public Health Rep, 1998. 113 Suppl 1: p. 67-74.
- Titus, S., et al., Bleach use and HIV seroconversion among New York City injection drug users. J Acquir Immune Defic Syndr, 1994. 7(7): p. 700-4.
- Riley, D., et al., Harm reduction: concepts and practice. A policy discussion paper. Subst Use Misuse, 1999. 34(1): p. 9-24.
- Pollack, H.A., Cost-effectiveness of harm reduction in preventing hepatitis C among injection drug users. Med Decis Making, 2001. 21(5): p. 357-67.
- Hagan, H., et al., Reduced risk of hepatitis B and hepatitis C among injection drug users in the Tacoma syringe exchange program. Am J Public Health, 1995. 85(11): p. 1531-7.
- Hurley, S.F., D.J. Jolley, and J.M. Kaldor, Effectiveness of needle-exchange programmes for prevention of HIV infection. Lancet, 1997. 349(9068): p. 1797-800.
- Return on Investment in Needle & Syringe Programs in Australia. 2002, Commonwealth Department of Health and Ageing; Health Outcomes International Pty Ltd; National Centre for HIV Epidemiology and Clinical Research; Drummond, Michael: Canberra.
- Des Jarlais, D.C., et al., HIV incidence among injecting drug users in New York City syringe-exchange programmes. Lancet, 1996. 348(9033): p. 987-91.
- Hagan, H., et al., Syringe exchange and risk of infection with hepatitis B and C viruses. Am J Epidemiol, 1999. 149(3): p. 203-13.
- Bruneau, J., et al., High rates of HIV infection among injection drug users participating in needle exchange programs in Montreal: results of a cohort study. Am J Epidemiol, 1997. 146(12): p. 994-1002.
- Taylor, A., et al., Prevalence of hepatitis C virus infection among injecting drug users in Glasgow 1990-1996: are current harm reduction strategies working? J Infect, 2000. 40(2): p. 176-83.
- Mansson, A.S., et al., Continued transmission of hepatitis B and C viruses, but no transmission of human immunodeficiency virus among intravenous drug users participating in a syringe/needle exchange program. Scand J Infect Dis, 2000. 32(3): p. 253-8.
- Hutchinson, S.J., et al., Prevalence of hepatitis C among injectors in Scotland 1989-2000: declining trends among young injectors halt in the late 1990s. Epidemiol Infect, 2002. 128(3): p. 473-7.
- Elliott, L., et al., The Winnipeg Injection Drug Epidemiology (W.I.D.E.) Study: A Study of the Epidemiology of Injection Drug Use and HIV Infection in Winnipeg, Manitoba. Final Report. 1999, Manitoba Health, Public Health and Epidemiology, Epidemiology Unit: Winnipeg.
- Roy, E., et al., Drug injection among street youth: the first time. Addiction, 2002. 97(8): p. 1003-9.
- Fry, C., S. Fox, and G. Rumbold, Establishing safe injecting rooms in Australia: attitudes of injecting drug users. Aust N Z J Public Health, 1999. 23(5): p. 501-4.
- Kerr, T., Safe Injection Facilities: Proposal for a Vancouver Pilot Project. 2000, Harm Reduction Action Society: Vancouver.
- Kent, H., Is Australia's safe injection site experiment bound for Vancouver? CMAJ, 2001. 164(9): p. 1332.
- Kondro, W., Advocacy group urges safe injection facilities for Canada's addicts. Lancet, 2002. 359(9315): p. 1415.
- Single, E. Harm Reduction as the basis for Hepatitis C policy and programming. in First Canadian Conference on Hepatitis C. 2001. Montreal: Canadian Centre on Substance Abuse.
- Dolan, K.A., et al., Drug consumption facilities in Europe and the establishment of supervised injecting centres in Australia. Drug and Alcohol Review, 2000. 19: p. 337-346.
- van Beek, I. and S. Gilmour, Preference to have used a medically supervised injecting centre among injecting drug users in Kings Cross, Sydney. Aust N Z J Public Health, 2000. 24(5): p. 540-2.
- Kaldor, J.M., et al., Six Month Process Report on the Medically Supervised Injecting Centre. 2001, University of New South Wales.
- Obadia, Y., et al., Syringe vending machines for injection drug users: an experiment in Marseilles, France. Am J Public Health, 1999. 89(12): p. 1852-4.
- Dodding, J. and M. Gaughwin, The syringe in the machine. Aust J Public Health, 1995. 19(4): p. 406-9.
- Lawlor, E., et al., Transmission rates of hepatitis C virus by different batches of a contaminated anti-D immunoglobulin preparation. Vox Sang, 1999. 76(3): p. 138-43.
[Previous] [Table of Contents]